Three separate signals converged on BG this week. The cost to borrow tripled, options traders shifted toward puts, and short interest began rebuilding after weeks of unwinding.
The standout move is in the lending market. Cost to borrow hit 1.26% on August 17 — up 220% in a single week from 0.39% the prior Monday. For context, BG has traded near 0.45–0.50% for most of the past six weeks. The sudden spike suggests fresh demand for borrowed shares, even as availability remains comfortably loose at 677%. That reading is well within normal territory — around six shares available for every one already borrowed — so there is no structural squeeze pressure. But the borrow cost move is notable precisely because availability hasn't tightened in kind. It points to a burst of short-selling demand rather than a supply constraint.
Options positioning has shifted in parallel. The put-call ratio reached 0.47 on August 17, a 2.0 standard deviation move above its 20-day mean of 0.36. This is the second consecutive week the ratio has printed at that level. Two weeks of elevated PCR — well above the mid-0.30s that dominated July — points to sustained hedging demand rather than a one-day spike.
The 52-week PCR range runs from 0.24 to 1.05, so the current reading is elevated but not extreme. Still, the consistency of the move since late July marks a shift from the optimism that prevailed through most of the summer.
Short interest adds a wrinkle. ORTEX estimates show SI at 3.46% of free float as of August 17 — modest in absolute terms, but the daily move tells a more complex story. After falling sharply through the week of August 11 (down roughly 12% over seven days), shares short jumped 13.8% on August 17 alone, back to 6.70 million shares. That single-day rebuild partially reverses the prior week's unwinding and aligns with the borrow cost spike. Someone built a meaningful new short position on Monday.
Analysts remain broadly constructive. Barclays carries a $150 target. JP Morgan and Morgan Stanley both hold Overweight ratings with targets of $134 and $140 respectively. The stock at $114.91 trades at a 19% discount to the mean analyst target of $141.
The last earnings print on July 29 moved the stock –10.5% on the day. Next results are due October 28.
See the live data behind this article on ORTEX.
Open BG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
